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Abstract
This study tested the hypothesis that elevated plasma adrenaline or metabolic
stress enhances exercise-induced PGC-1a mRNA and intracellular signaling in
human muscle. Trained (VO2-max: 53.8  1.8 mL min1 kg1) male subjects
completed four different exercise protocols (work load of the legs was
matched): C – cycling at 171  6 W for 60 min (control); A – cycling at
171  6 W for 60 min, with addition of intermittent arm exercise (98  4 W).
DS – cycling at 171  6 W interspersed by 30 sec sprints (513  19 W) every
10 min (distributed sprints); and CS – cycling at 171  6 W for 40 min fol-
lowed by 20 min of six 30 sec sprints (clustered sprints). Sprints were followed
by 3:24 min:sec at 111  4 W. A biopsy was obtained from m. vastus lateralis
at rest and immediately, and 2 and 5 h after exercise. Muscle PGC-1a mRNA
content was elevated (P < 0.05) three- to sixfold 2 h after exercise relative to
rest in C, A, and DS, with no differences between protocols. AMPK and p38
phosphorylation was higher (P < 0.05) immediately after exercise than at rest
in all protocols, and 1.3- to 2-fold higher (P < 0.05) in CS than in the other
protocols. CREB phosphorylation was higher (P < 0.05) 2 and 5 h after exercise
than at rest in all protocols, and higher (P < 0.05) in DS than CS 2 h after exer-
cise. This suggests that neither plasma adrenaline nor muscle metabolic stress
determines the magnitude of PGC-1a mRNA response in human muscle. Fur-
thermore, higher exercise-induced changes in AMPK, p38, and CREB phospho-
rylation are not associated with differences in the PGC-1a mRNA response.
Introduction
Endurance exercise increases the oxidative capacity of
skeletal muscle through increased mitochondrial biogenesis
and vascularization (Booth et al. 2012). This is exemplified
by increases in the content of proteins in the respiratory
chain (Hood 1985) cytochrome (cyt) c, and the regulator of
angiogenesis, vascular endothelial growth factor (VEGF),
in human skeletal muscle with exercise (Gustafsson et al.
1985; Baar et al. 2002; Olesen et al. 2014, 2015). Mecha-
nisms underlying such long-term adaptations have been
suggested to include cumulative effects of transient gene
responses to each single exercise bout (Neufer et al. 1996).
In accordance, studies have reported exercise-induced
transient increases in both Cyt c and VEGF mRNA in
human skeletal muscle (Hiscock et al. 2003; Jensen et al.
2004; Leick et al. 2010).
The transcriptional coactivator peroxisome proliferator-
activated receptor-ϒ coactivator (PGC-1a), which is
known as a key regulator of mitochondrial biogenesis
and vascularization, has been suggested to elicit exercise-
induced transcriptional regulation of oxidative and
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angiogenic factors in skeletal muscle. In addition, PGC-1a
transcription and mRNA content in skeletal muscle have
been shown to be upregulated after a single exercise bout
in rats (Baar et al. 2002), mice (Leick et al. 2008), and
humans (Pilegaard et al. 2003). Therefore, it has been sug-
gested that exercise-induced transcriptional regulation of
PGC-1a is an initial event in the concomitant regulation of
oxidative and angiogenic markers in skeletal muscle.
The PGC-1a mRNA has been shown to increase in
human skeletal muscle after both prolonged moderate
intensity exercise and brief intense interval exercise
(Gibala et al. 1985), and the exercise-induced PGC-1a
mRNA response in human skeletal muscle has been
demonstrated to be intensity dependent (Egan et al. 2010;
Nordsborg et al. 2010). However, it is unclear how exer-
cise-induced PGC-1a transcription is regulated. PGC-1a
transcription is believed to be regulated via the CaMK/
cAMP-response element binding (CREB) pathway (Hand-
schin et al. 2003) or p38 mitogen-activated protein kinase
(p38) (Akimoto et al. 2005; Wright et al. 2007). In accor-
dance, p38 and CREB have been reported to be phospho-
rylated and thereby activated in skeletal muscle by
contractile activity in mice (Akimoto et al. 2005; Bruno
et al. 2014) and humans (Boppart et al. 2000; Egan et al.
2010). Furthermore, the cAMP-response element and the
binding sites of the suggested p38 targets MEF2 and ATF2
have been located in the PGC-1a promoter, further sup-
porting that CREB and p38 contribute in the regulation of
PGC-1a transcription. An autoregulatory loop controls
PGC-1a expression in skeletal muscle (Handschin et al.
2003), and exercise stimulates PGC-1a transcription
through activation of the p38 MAPK pathway (p38) (Aki-
moto et al. 2005). Moreover, p38 has been reported to
phosphorylate PGC-1a at three residues leading to a more
active PGC-1a protein (Puigserver et al. 2001), which may
indicate that p38 regulates PGC-1a activity in response to
exercise. In accordance, a human study has reported that
PGC-1a mRNA induction was preceded by p38 signaling
in skeletal muscle (Gibala et al. 1985). However, whether
differences in exercise-induced PGC-1a mRNA responses
are associated with differences in the potential upstream
PGC-1a regulators, p38 and CREB, remain unresolved.
The finding that adrenaline injections increased PGC-
1a mRNA in mouse skeletal muscle (Chinsomboon et al.
2009) suggests that adrenaline may play a role in exercise-
induced PGC-1a transcriptional regulation. This is further
supported by studies showing that injections of the beta2-
adrenoceptor agonist clenbuterol increased PGC-1a
mRNA more than 30-fold in mouse skeletal muscle
(Miura et al. 2007; Chinsomboon et al. 2009) and pre-
treatment with the beta-antagonist propranolol inhibited
this increase (Miura et al. 2007). Similarly, an exercise-
induced increase in PGC-1a mRNA in mouse skeletal
muscle was almost blunted by pretreatment with propra-
nolol (Miura et al. 2007). However, a role of adrenaline
in exercise-induced regulation of PGC-1a expression in
humans is less clear. Beta-antagonist blockade during
endurance exercise has been reported to blunt the
increase in maximal activity of selected oxidative enzymes
(Svedenhag et al. 1984; Wolfel et al. 1986), while another
human study did not observe alterations in markers of
mitochondrial biogenesis with beta2-adrenergic stimula-
tion (Robinson et al. 2010).
The observation that PGC-1a mRNA remains elevated
in human skeletal muscle 8 h after exercise when muscle
glycogen content is maintained low through diet manipu-
lation (Pilegaard et al. 2005) may suggest that the intra-
cellular energy store also affects the PGC-1a mRNA level.
This is further supported by the augmented PGC-1a
mRNA response when exercise is performed with reduced
muscle glycogen (Psilander et al. 2013). Together, these
findings may indicate that the intracellular energy state
also influences PGC-1a transcription in skeletal muscle.
AMP-activated protein kinase (AMPK) is known as an
intracellular energy sensor, activated by phosphorylation
during exercise (Winder and Hardie 1996). In addition,
the observation that an exercise-induced PGC-1a mRNA
induction was preceded by increased AMPK phosphoryla-
tion in human skeletal muscle (Gibala et al. 1985), and
the identification of a DNA sequence mediating transcrip-
tional regulation of PGC-1a during AMPK activation
(Irrcher et al. 2008) further support this possibility.
Finally, in vitro experiments have indicated that AMPK
phosphorylates PGC-1a on two residues (Jager et al.
2007) suggesting that AMPK also regulates PGC-1a activ-
ity in skeletal muscle in response to exercise.
The present study tested the hypothesis that elevated
levels of plasma adrenaline or metabolic stress enhances
PGC-1a mRNA responses in human skeletal muscle with
concomitant effects on downstream targets, and that dif-
ference in AMPK, p38, and CREB signaling between the
different exercise modalities are associated with corre-
sponding differences in PGC-1a mRNA responses.
Materials and methods
Subjects
The study comprised 10 moderately trained male subjects
with an average age of 25.8  5.9 years (mean  SD)
(range: 21–34 years), body mass 81.3  9.4 (57.7–91.1) kg,
height 184  6 (170–190) cm, body mass index 23.9  2.0
(20.0–26.8) kg m2, and maximum oxygen uptake (VO2-
max) 53.8  5.7 (46.2–60.6) mL kg1 min1. The subjects
were engaged in 1–3 weekly training sessions (team sports,
endurance, and/or strength training). Subjects were
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informed of any risks and discomforts associated with the
experiments before giving their written informed consent
to participate. The study was approved by the Ethics Com-
mittee of Copenhagen and Frederiksberg communities and
adheres to the principles of the Declaration of Helsinki and
Title 45, U.S. Code of Federal Regulations, Part 46, Protec-
tion of Human Subjects, Revised 23 June 2005, effective 23
June 2005.
Study design
The study was designed as a randomized crossover study
comparing four different exercise protocols conducted at
separate experimental days. The study period was
24  2 days (19–41 days). At least 48 h prior to the first
experimental day, subjects were interviewed and com-
pleted a VO2-max test consisting of a 5-min cycling bout
at 100–150 W followed by 5 min at 175–225 W (depend-
ing on fitness level), and then, work load was increased
by 25 W min1 until volitional exhaustion. If pedaling
frequency dropped below 50 rpm, the test was terminated
immediately. The incremental peak power output (iPPO)
was calculated based on the performance during the
incremental test. Pulmonary oxygen uptake was measured
(Oxycon Pro, Viasys Healthcare, Hoechberg, Germany)
throughout the test and VO2-max was determined as the
highest value achieved during a 30-s period. Criteria used
for achievement of VO2-max were a plateau in VO2
despite an increased workload and a respiratory exchange
ratio above 1.10. VO2 during sub- and maximal cycling
was used to calculate individual workloads (60% of VO2-
max) on experimental days.
Experimental period
First experimental day was commenced 6  1 days after
the screening. The order of experimental days was ran-
domized. During the experimental period subjects main-
tained their habitual lifestyle and training routines. The
four experimental days consisted of either continuous
cycling at an intensity corresponding to 60% VO2-max
(171  6 W) with or without addition of intermittent
arm cranking, interspersed or followed by clustered
repeated 30 sec sprints (513  19 W) (Fig. 1):
C: 60 min of continuous cycling at 171  6 W (con-
trol).
A: 60 min of continuous cycling at 171  6 W with
addition of twelve 1 min bouts (98  4 W) of intermit-
tent arm cranking every 5 min (additional arm exercise).
DS: 60 min of continuous cycling at 171  6 W inter-
spersed by 30 sec sprints (513  19 W) and cycling at
111  4 W for 3:24 min:sec every 10 min (distributed
sprints).
CS: 40 min of continuous cycling at 171  6 W
followed by 20 min consisting of six 30 sec sprints
(513  19 W) interspersed by 3:24 min:sec at 111  4 W
(clustered sprints).
The workload of the legs was matched between experi-
mental days, eliciting an average intensity of 60% of VO2-
max (171  6 W). In A, the average heart rate (HR) and
pulmonary oxygen uptake (VO2) were higher than in the
other protocols, due to addition of intermittent arm
cranking (98  4 W) (Table 2).
The rationale for choosing the specific exercise proto-
cols were that C was control cycling, with a very modest
anaerobic energy contribution, thus limited stimulation of
adrenaline production, utilization of muscle creatine
phosphate (CP), accumulation of muscle lactate, and
reduced muscle pH. In A, we included 1 min arm-exer-
cise bouts every 5 min (twelve in total) to stimulate the
production of adrenaline. With the distributed sprint pro-
tocol (DS) we wanted to induce temporary reductions in
muscle CP, accumulation of muscle lactate and decreases
in muscle pH. The clustered sprint protocol (CS) was to
induce a marked metabolic response, with repeated bouts
of high utilization of muscle CP, accumulation of muscle
lactate, and reduction in muscle pH.
On experimental days, subjects reported to the labora-
tory in the morning (between 8 and 9 AM) 2 h after con-
sumption of a self-chosen standardized breakfast. During
the 60 min of exercise, pulmonary VO2 was measured
(Oxycon Pro, Viasys Healthcare, Hoechberg, Germany) at
5–10 and 39–45 min in C, at 3–11 and 38–46 min in A,
at 4–14 and 37–44 min in DS, and at 5–10 and
37–46 min in CS. In addition, HR was measured (Polar
team system, Polar, Electro Oy) throughout the exercise
protocol.
A muscle biopsy was collected at rest, immediately,
and 2 and 5 h after exercise using the percutaneous
needle biopsy technique (Bergstrom 1975) with suction.
Within 60 min of arrival at the laboratory, local anes-
thesia (1 mL of lidocaine, 20 mg mL1 without adrena-
line) was administered over m. vastus lateralis, and two
3-mm incisions were made. A resting muscle biopsy
(rest) was obtained from the most distal incision, and
the second incision was used for a second muscle
biopsy sampled immediately after exercise (0 h). Addi-
tional muscle biopsies were sampled 2 and 5 h into
recovery in the opposite leg through separate incisions.
The muscle biopsy samples were immediately frozen in
liquid nitrogen and stored (80°C) until analysis. Blood
samples were taken from a catheter (18 gauge, 32 mm)
inserted in an antecubital vein prior to exercise. A
blood sample was collected at rest, at 23, 39, and
60 min of exercise and 3, 10, 120, and 300 min after
exercise.
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Analyses
Blood and muscle analyses
For the determination of plasma lactate and glucose,
blood samples were drawn in heparinized 2 mL syringes
and immediately analyzed (ABL 800 Flex, Radiometer,
Copenhagen). For the analyses of plasma catecholamines
(Plasma ELISA High Sensitive kit, LDN, Nordhorn, Ger-
many), blood samples were collected in 5 mL syringes
and transferred to an Eppendorf tube containing 30 lL
EDTA (0.2 mol/L), after which they were spun at 20,000g
for 2 min to collect plasma, which was stored at 20°C
until analysis.
Approximately 20 mg of the muscle samples were
frozen separately for mRNA analyses. The remaining
part of the muscle sample was immediately frozen in
liquid nitrogen and stored at 80°C before being freeze
dried for 48 h and dissected free of all nonmuscle
elements. Dissection was performed under a stereo
microscope with an ambient temperature of ~18°C and
a relative humidity below 30%. After dissection, muscle
tissue was weighed and separated into different tubes
for analyses.
Muscle glycogen
Muscle glycogen was determined on freeze-dried muscle
tissue (~2 mg dw) before (rest) as well as immediately,
and 2 and 5 h after exercise by acid hydrolysis at 100°C
for 2 h followed by determination of glycosyl units using
the hexokinase method (Lowry and Passonneau 1972).
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Figure 1. Schematic presentation of the four experimental days consisting of 60 min of cycling at an average intensity corresponding to 60%
of VO2-max (171  6 W) as (A) continuous cycling (C), (B) continuous cycling with intermittent arm exercise (A), (C) continuous cycling
interspersed by six 30 sec sprints (513  19 W) and cycling at 111  4 W for 3:24 min:sec every 10 min (DS), and (D) 40 min of cycling
followed by 20 min with six 30 sec sprints (513  19 W) interspersed by 3:24 min:sec at 111  4 W (CS). On experimental days, muscle
biopsies were taken at rest as well as immediately, and 120 and 300 min after exercise. Blood samples were taken at rest, during (23, 39, and
60 min) and after (3, 10, 120, and 300 min) exercise.
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Muscle Metabolites
Muscle lactate, ATP, and CP were determined on freeze-
dried muscle tissue (~2 mg dry wt) before (rest) as well as
immediately, and 2 and 5 h after exercise by extraction in
3 mol/L perchloric acid followed by fluorometric analyses
as described previously (Lowry and Passonneau 1972).
Muscle proteins
Muscle lysate was produced from ~4 to 6 mg dry weight
by homogenization in an ice-cold buffer (10% glycerol,
20 mmol/L Na-pyrophosphate, 150 nmol/L NaCl,
50 mmol/L HEPES, 1% NP-40, 20 mmol/L b-glyceropho-
sphate, 10 mmol/L NaF, 1 mmol/L EDTA, 1 mmol/L
EGTA, 20 lg/mL aprotinin, 10 lg/mL leupeptin, 2 mmol/L
Na3VO4, 3 mmol/L benzamidine, pH 7.5) for 2 min at 30
oscillations per second in a TissueLyser (TissueLyser II,
Qiagen, Valencia, CA, USA). The samples were set to
rotate end over end for 1 h at 4°C followed by centrifuga-
tion at 17,500g for 20 min at 4°C. The lysates were
collected as the supernatant. The protein content in the
lysates was determined by the bicinchoninic acid method
(Pierce Chem, Comp., IL) and lysates were prepared with
sample buffer containing sodium dodecyl sulfate (SDS)
and boiled for 3 min at 96°C. Phosphorylation levels and
protein content were measured by SDS-PAGE and western
blotting using self-casted gels. Specific amounts of total
protein were loaded for each sample. PVDF membranes
were blocked in 3% fish gel. Primary antibodies used were
phospho-AMPK (#2535S, Cell Signaling), AMPKa2 pro-
tein (#G3013, Santa Cruz Biotechnology), phospho-ACC
(07-303, Millipore), phospho-p38 (#4511, Cell Signaling),
P38 protein (#9212, Cell Signaling), phospho-CREB
(#9191, Cell Signaling), and CREB protein (#9197, Cell
Signaling). Secondary antibodies were HRP conjugated
(Dako, Glostrup, Denmark). LuminataTM Classico Western
HRP Substrate (Millipore, Denmark) was used to detect
protein and phosphorylation. Band intensity was quanti-
fied using ImageQuant Las 4000 (GE Healthcare, Munich,
Germany) and ImageQuant Imaging software. Protein con-
tent and phosphorylation were expressed in arbitrary units
relative to control samples loaded on each site of each gel.
Phosphorylation levels were normalized to total protein
content of the target protein.
RNA isolation, reverse transcription, and real-time
PCR
Total RNA was isolated from 15 to 20 mg muscle tissue
(wet weight) by a modified guanidinium thiocyanate–
phenol–chloroform extraction method from Chomczynski
and Sacchi (1987) as described previously (Pilegaard et al.
2000) except for the use of a TissueLyser (TissueLyser II,
Qiagen, Valencia, CA, USA) for homogenization.
Superscript II RNase H-system and Oligo dT (Invitro-
gen, Carlsbad, CA, USA) were used to reverse transcribe
the mRNA to cDNA as described previously (Pilegaard
et al. 2000).
Quantification of cDNA as a measure of mRNA content
of a given gene was performed by real-time PCR using an
ABI 7900 sequence-detection system (Applied Biosystems,
Foster City, CA, USA). Primers and TaqMan probes were
designed from human specific databases from ensemble
(www.ensembl.org/Homo_sapiens/Info/Index) and Primer
Express (Applied Biosystems) and are presented in
Table 1. Self-designed TaqMan probes were labeled with
50-6-carboxyfluorescein (FAM) and 30-6-carboxy-N,N,N0,
N0-tetramethylrhodamine (TAMRA) and obtained from
TAG Copenhagen (Copenhagen, Denmark). Cyclophilin A
mRNA was amplified using a 50-VIC- and 30-TAMRA-
labeled predeveloped assay reagent (Applied Biosystems).
Cyclophilin A was used as endogenous control as there
was no significant difference between protocols and/or
time points. Real-time PCR was performed in triplicates in
a total reaction volume of 10 lL using Universal Master-
mix with UNG (Applied Biosystems). The obtained cycle
threshold values reflecting the initial content of the specific
transcript in the samples were converted to a relative
amount by using standard curves constructed from serial
Table 1. Primers and TaqMan probe sequences used for real-time PCR.
Forward primer Reverse primer
PGC-1a 50-CAAGCCAAACCAACAACTTTATCTCT-30 50-CACACTTAAGGTGCGTTCAATAGTC-30
VEGF 50-CTTGCTGCTCTACCTCCACCAT-30 50-ATGATTCTGCCCTCCTCCTTCT-30
Cyt c 50-GGTCTCTTTGGGCGGAAGAC-30 50-CTCTCCCCAGATGATGCCTTT-30
TaqMan probe
PGC-1a 50-AGTCACCAAATGACCCCAAGGGTTCC-30
VEGF 50-AAGTGGTCCCAGGCTGCACCCA-30
Cyt c 50-CCCTGGATACTCTTACACAGCCGCCAA-30
PGC-1a, peroxisome proliferator-activated receptor-ϒ coactivator-1a; VEGF, vascular endothelial growth factor; Cyt c, cytochrome c.
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dilution of a pooled sample made from all samples. For
each cDNA sample, the mRNA content of the given target
was normalized to Cyclophilin A mRNA.
Statistics
Values are presented as mean (SE). All subjects
(n = 10) contributed to blood analyses, muscle glycogen,
ATP, creatine phosphate, lactate, and protein analysis,
while eight subjects contributed to the mRNA analyses
due to extremely low RNA yield in two of the subjects.
Two-way analysis of variance for repeated measures was
applied to evaluate the effect of protocol and time points
on plasma adrenaline, muscle glycogen, muscle ATP,
muscle creatine phosphate, muscle lactate, mRNA, phos-
phorylation levels, and protein content. If a main effect
was observed, a Student–Newman–Keul’s post hoc test
was used to locate differences. A significant level of
P < 0.05 was chosen, and statistical calculations were per-
formed using SigmaPlot Version 12.5. Normality was
tested before each statistical test. Sample power analysis
was performed prior to the study with PGC-1a mRNA, a
fold change of 2, a power of 0.8, and a = 0.05 giving a
minimum required sample size of n = 8. Based on previ-
ous experiments, we expected a dropout rate of up to
20%, thus recruiting 10 subjects for this experiment.
Results
Heart rate and oxygen uptake
Heart rate (HR) after 23 min of exercise was lower
(P < 0.05) in C, DS, and CS than A, and lower after 39
and 60 min (P < 0.05) in C and CS than A (Table 2). In
addition, HR after 60 min was lower (P < 0.05) in C and
CS than DS and lower (P < 0.05) in C than CS. There
was no difference in pulmonary oxygen uptake between
protocols after 9 and 39 min of exercise (Table 2).
Plasma adrenaline
Plasma adrenaline after 23 and 39 min of exercise was
not different between protocols, whereas plasma adrena-
line was higher (P < 0.05) after 60 min of exercise in A,
DS, and CS than in C, and higher (P < 0.05) in DS than
in A (Fig. 2).
Plasma lactate and glucose
Plasma lactate after 23 and 39 min of exercise was higher
(P < 0.05) in DS and A than in C, and higher (P < 0.05)
in DS than in A (Table 3). At the end of exercise, plasma
lactate was higher (P < 0.05) in CS than the other proto-
cols, and higher (P < 0.05) in A and DS than in C.
Plasma lactate remained higher in A, DS, and CS after 10
but not 120 min of recovery.
In C, plasma glucose after 23 min of exercise was lower
(P < 0.05) than at rest. After 39 min of exercise, plasma
glucose was not different between protocols, whereas
plasma glucose was higher (P < 0.05) in CS immediately,
3 and 10 min after exercise than in the other protocols,
and 3 min after exercise it was higher (P < 0.05) in A
and DS than C.
Muscle ATP and CP
Muscle ATP before and after exercise was not different
between protocols. Muscle CP at the end of exercise was
lower (P < 0.05) in DS and CS than in C and A (Table 4).
Muscle glycogen, glucose, glucose-6-
phosphate, and lactate
Muscle glycogen in DS was lower (P < 0.05) than C and
A, and lower (P < 0.05) in CS than A at the end of exer-
cise (Fig. 3). Muscle glycogen 2 and 5 h after exercise was
not different between protocols.
Table 2. Heart rate (HR) and pulmonary oxygen uptake ( _VO2) during 60 min of cycling exercise (n = 10) as continuous cycling (C), continu-
ous cycling with arm exercise (A), continuous cycling with sprints performed every 10 min (DS), and continuous cycling followed by repeated
sprints for 20 min (CS).
Exercise (min) C A DS CS
HR (bpm) 23 143  51 157  5 140  61 143  31
39 149  61 161  5 155  5 149  31
60 155  53 177  5 172  4 164  41,2
_VO2 (L/min) 9 2.68  0.071 2.85  0.10 2.72  0.071 2.75  0.081
39 2.86  0.071 2.94  0.11 2.76  0.081 2.78  0.081
Values are presented as mean  SE
1Different (P < 0.05) from A.
2Different (P < 0.05) from DS
3Different (P < 0.05) from all other protocols.
2016 | Vol. 4 | Iss. 14 | e12844
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In CS, muscle glucose after exercise was higher
(P < 0.05) than in the other protocols, and higher
(P < 0.05) in DS than in C and A. In DS, muscle glu-
cose-6-phosphate (G-6-P) was higher (P < 0.05) than in
C and A at the end of exercise (Table 4). At the end of
exercise, muscle lactate was higher (P < 0.05) in CS than
in the other protocols, and higher (P < 0.05) in DS than
in C and A (Table 4).
P
la
sm
a 
A
dr
en
al
in
e 
(n
m
ol
/L
)
0
1
2
3
4
5
6
a
* *
*
*
*
*
* *
*
*
*
*
a
a
b
Rest 23 39 60 Rest 23 39 60 Rest 23 39 60 Rest 23 39 60
C                       A                   DS CS
Figure 2. Venous plasma adrenaline concentrations before (Rest; black bars), during (23 min: dark gray bars; 39 min: light gray bars; 60 min;
white bars) 60 min of cycling at 171  6 W on average as continuous control cycling (C), continuous cycling with arm exercise (A), continuous
cycling interspersed by six 30 sec sprints (513  19 W) and cycling at 111  4 W for 3:24 min:sec every 10 min (DS), and 40 min of control
cycling followed by 20 min with six 30 sec sprints (513  19 W) interspersed by 3:24 min:sec at 111  4 W (CS). Values (n = 10) are
presented as mean  SE. *Different (P < 0.05) from rest. aDifferent (P < 0.05) from C. bDifferent (P < 0.05) from A.
Table 3. Plasma glucose (mmol/L) and lactate (mmol/L) before (Rest), during and after 60 min of exercise (n = 10) as continuous cycling (C),
continuous cycling with arm exercise (A), continuous cycling with sprints performed every 10 min (DS), and continuous cycling for 40 min fol-
lowed by repeated sprints for 20 min (CS).
Glucose (mmol/L) Lactate (mmol/L)
C A DS CS C A DS CS
Rest 5.8  0.3 5.6  0.3 5.4  0.2 5.5  0.2 1.1  0.2 1.1  0.2 1.5  0.3 1.1  0.1
Exercise (min) C A DS CS C A DS CS
23 4.6  0.2* 5.0  0.2 5.6  0.24 5.0  0.1 2.4  0.9 5.9  0.8*1,3 9.4  1.9*,4 2.5  0.6
39 5.1  0.1 5.5  0.2 5.8  0.4 5.3  0.1 2.4  0.8 6.1  0.9*1,3 6.0  2.0*1,3 2.1  0.4
60 5.2  0.1 5.9  0.21 5.7  0.3 6.7  0.3*4 2.3  0.6 7.3  0.8*1 8.9  1.6*1 13.2  1.5*4
Recovery (min) C A DS CS C A DS CS
3 5.6  0.1 6.3  0.21 6.3  0.4*1 7.0  0.4*4 1.8  0.3 6.7  0.9*1 10.7  1.7*1,2 13.7  1.5*4
10 5.5  0.2 6.0  0.2 5.7  0.5 6.6  0.3*4 1.6  0.5 4.9  0.8*1 7.5  1.5*1,2 11.3  1.6*4
120 5.3  0.1 5.2  0.1 5.1  0.1 5.2  0.1 0.8  0.1 0.9  0.1 1.2  0.2 1.3  0.1
300 5.1  0.1 5.1  0.1 5.0  0.2 5.1  0.1 0.7  0.1 0.8  0.1 0.9  0.1 0.9  0.1
Values are presented as mean  SE.
*Different (P < 0.05) from rest.
1Different (P < 0.05) from C.
2Different (P < 0.05) from A.
3Different (P < 0.05) from CS.
4Different (P < 0.05) from all other protocols.
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Muscle mRNA levels
Muscle PGC-1a mRNA content was elevated (P < 0.05)
three- to sixfold relative to rest 2 h after exercise in C, A,
and DS with no differences between protocols (Fig. 4A).
Muscle VEGF mRNA content was 1- to 3.2-fold
higher (P < 0.05) relative to rest 2 h after exercise in DS
(P < 0.05) and 5 h after exercise in C (P < 0.05), with no
differences between protocols (Fig. 4B). Cyt c mRNA was
unaffected by the exercise bout in all protocols with no
differences between protocols (Fig. 4C).
Protein content and phosphorylation status
of skeletal muscle
In CS, AMPKa2 protein content was higher (P < 0.05) 0,
2, and 5 h after exercise than at rest with no differences in
the other protocols. No difference in AMPKa2 protein was
observed between protocols (Fig. 5A). In all protocols,
AMPK and ACC phosphorylation was higher (P < 0.05) at
the end of exercise than at rest, and AMPK phosphoryla-
tion was ~1.3-fold higher (P < 0.05) in CS than in the
other protocols (Fig. 5A and 5B). In addition, ACC
Table 4. Muscle ATP, creatine phosphate (CP), glucose, glucose-6-phosphate (G-6-P) and lactate (mmol∙kg dw1) before (Pre) and immedi-
ately after (Post) 60 min of continuous cycling exercise (n = 10) consisting of 60 min of continuous cycling (171  20 W) (C), 60 min of exer-
cise (n = 10) as continuous cycling (C), continuous cycling with arm exercise (A), continuous cycling with sprints performed every 10 min (DS),
and continuous cycling for 40 min followed by repeated sprints for 20 min (CS).
C A DS CS
Pre Post Pre Post Pre Post Pre Post
ATP 25.3  1.5 23.3  1.0 23.9  1.3 23.1  1.5 26.7  0.8 24.2  1.5 25.9  1.7 23.4  1.4
CP 73.3  3.1 49.5  4.1* 73.5  3.3 46.9  6.4* 78.9  20.7 20.7  4.1*1, 2 74.1  5.0 26.7  4.3*1, 2
Glucose 2.3  0.4 2.5  0.4 2.8  0.2 2.8  0.5 1.7  0.3 6.9  1.4*1, 2 1.4  0.1 14.0  2.1*3
G-6-P 1.3  0.6 1.8  0.6 2.3  0.9 3.0  0.7 1.1  0.4 4.0  1.3* 1.0  0.2 5.7  1.5*1, 2
Lactate 4.4  1.6 12.2  3.0* 9.6  3.3 17.1  3.2* 4.2  1.5 62.4  5.2*1, 2 3.7  1.0 74.3  5.2*3
Values are presented as mean  SE.
*Different (P < 0.01) from rest.
1Different (P < 0.05) from C.
2Different (P < 0.05) from A.
3Different (P < 0.05) from all other protocols.
Figure 3. Muscle glycogen levels (mmol∙kg dw1) before (rest; black bars), immediately (0 h; dark gray bars), 2 h (light gray bars), and 5 h
(white bars) after 60 min of cycling (171  6 W) as continuous control cycling (C), continuous cycling with arm exercise (A), continuous cycling
interspersed by six 30 sec sprints (513  19 W) and cycling at 111  4 W for 3:24 min:sec every 10 min (DS), and 40 min of control cycling
followed by 20 min with six 30 sec sprints (513  19 W) interspersed by 3:24 min:sec at 111  4 W (CS). Values (n = 10) are presented as
meanSE. *Different (P < 0.05) from rest. aDifferent (P < 0.05) from C. bDifferent (P < 0.05) from A.
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phosphorylation immediately after exercise was 1.3-fold
higher (P < 0.05) in CS than in A, but not different from C
and DS.
There were no changes in p38 protein content in any
of the protocols, but p38 protein content was overall
lower (P < 0.05) in CS than in the other protocols. At
the end of exercise p38 phosphorylation was higher
(P < 0.05) than at rest in all protocols, and p38 phospho-
rylation was 1.3-fold higher (P < 0.05) in DS than in C
and 1.6- to 2-fold higher (P < 0.05) in CS than the other
protocols (Fig. 5C).
There was no effect of exercise or difference between
protocols in CREB content. In all protocols, CREB phos-
phorylation was lower (P < 0.05) immediately after exer-
cise than at rest with no difference between protocols
(Fig. 5D). CREB phosphorylation was higher (P < 0.05)
2 h after exercise than at rest in C, A, and DS and higher
(P < 0.05) 5 h after exercise than at rest in C, A, and CS.
CREB phosphorylation was higher (P < 0.05) in DS than
in CS 2 h after exercise.
Discussion
The main findings of the present study were that neither
differences in plasma adrenaline levels nor differences in
muscle lactate, glycogen, and creatine phosphate affected
the exercise-induced PGC-1a mRNA response in human
skeletal muscle. In addition, differences in exercise-
induced regulation of AMPK, p38, and CREB phosphory-
lation between protocols were not associated with differ-
ences in muscle PGC-1a mRNA response.
The current finding that exercise-induced PGC-1a
mRNA response was the same with and without addi-
tional arm exercise (C vs. A) despite a marked difference
in plasma adrenaline during exercise is in contrast to
findings in studies of mice. In mice, injections of adrena-
line or beta-adrenergic agonists induced PGC-1a mRNA
in skeletal muscle, whereas beta-adrenergic antagonists
blocked exercise-induced PGC-1a mRNA response (Miura
et al. 2007; Chinsomboon et al. 2009; Tadaishi et al.
2011). It should be noted that the lack of elevated plasma
adrenaline at 23 and 39 min of exercise in the protocol
with arm exercise may have been a result of the samples
being collected 3–4 min following arm exercise.
It cannot be excluded, however, that the period with
elevated plasma adrenaline concentrations in the protocol
with arm exercise may have been insufficient, and that
longer exposure to high-adrenaline levels may be needed
to elevate the muscle PGC-1a mRNA response to exercise.
On the other hand, another human study observed no
effects of infusion of the nonspecific beta2-adrenoceptor
agonist isoproterenol on mRNA content of PGC-1a or
mitochondrial markers (Robinson et al. 2010), suggesting
A
B
C
Figure 4. (A) Peroxisome proliferator-activated receptor-ϒ
coactivator-1a (PGC-1a), (B) vascular endothelial growth factor
(VEGF), and (C) cytochrome c (Cyt C) mRNA content normalized to
cyclophilin A mRNA content in vastus lateralis before (rest; black
bars), immediately (0 h; dark gray bars), 2 h (light gray bars), and
5 h (white bars) after 60 min of cycling (171  6 W) as continuous
control cycling (C), continuous cycling with arm exercise (A),
continuous cycling interspersed by six 30 sec sprints (513  19 W)
and cycling at 111  4 W for 3:24 min:sec every 10 min (DS), and
40 min of control cycling followed by 20 min with six 30 sec
sprints (513  19 W) interspersed by 3:24 min:sec at 111  4 W
(CS). Values are presented as meanSE; n = 8. *Different
(P < 0.05) from rest.
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that regulation of the PGC-1a mRNA response differs in
humans and rodents (Miura et al. 2007; Chinsomboon
et al. 2009; Tadaishi et al. 2011).
Plasma lactate as well as muscle lactate and G-6-P
levels were higher and muscle CP lower in the sprinting
protocols (DS and CS) than the continuous moderate
intensity cycling protocols (C and A), which indicates
that the metabolic stress was more pronounced in the
sprinting protocols. Thus, the observation that PGC-1a
mRNA levels were similar after these protocols suggests
that metabolic stress is not a determining factor in
exercise-induced PGC-1a mRNA response in human
skeletal muscle. It has been observed that reduced muscle
glycogen is associated with higher exercise-induced PGC-
1a mRNA levels in human skeletal muscle (Pilegaard
et al. 2005; Psilander et al. 2013). However, the observa-
tion that differences in muscle glycogen levels between
protocols were not associated with differences in PGC-1a
mRNA suggests that the level of glycogen is not critical
for muscle PGC-1a mRNA response. It should be noted,
however, that the muscle glycogen levels differed less
than 100 mmol kg dw1 between the protocols in the
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Figure 5. (A) AMP-activated protein kinase (AMPK)Thr172 phosphorylation normalized to AMPKa2 protein, (B) acetyl-CoA carboxylase
(ACC)Ser79 phosphorylation, (C) p38 mitogen-activated protein kinase (p38)Thr180/Tyr182 phosphorylation normalized to p38 protein content, and
(D) cAMP-response element-binding protein (CREB)Ser133 phosphorylation normalized to total CREB protein content before (rest; black bars),
immediately (0 h; dark gray bars), 2 h (light gray bars), and 5 h (white bars) after 60 min of cycling (171  6 W) as continuous control cycling
(C), continuous cycling with arm exercise (A), continuous cycling interspersed by six 30 sec sprints (513  19 W) and cycling at 111  4 W for
3:24 min:sec every 10 min (DS), and 40 min of control cycling followed by 20 min with six 30 s sprints (513  19 W) interspersed by
3:24 min:s at 111  4 W (CS). Protein levels are given in arbitrary units (AU). Values are presented as meanSE; n = 10. *Different (P < 0.05)
from rest. aDifferent (P < 0.05) from C. bDifferent (P < 0.05) from A. dDifferent (P < 0.05) from CS. eDifferent (P < 0.05) from all other
protocols.
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present study, whereas previous studies reported differ-
ences of 200–300 mmol kg dw1 in muscle glycogen
(Pilegaard et al. 2005; Psilander et al. 2013). In addition,
the muscle PGC-1a mRNA response has been shown to
differ between untrained and trained subjects exercising
at the same absolute work load without differences in
muscle glycogen immediately after exercise (Nordsborg
et al. 2010). Taken together, these findings suggest that
muscle glycogen level is not a determining factor for
exercise-induced PGC-1a mRNA response in human
skeletal muscle.
The present findings that exercise-induced AMPK,
ACC, and CREB phosphorylation differed between the
exercise protocols and that PGC-1a mRNA levels were
not different, do not support that AMPK and CREB sig-
naling are major mediators of the PGC-1a mRNA
response. In contrast, studies in rodents have reported
that AICAR treatment (Jorgensen et al. 2005) and CREB-
mediated Ca2+ signaling elevated PGC-1a mRNA and
protein, respectively, in skeletal muscle, suggesting that
AMPK and Ca2+ signaling regulates PGC-1a expression.
These differences may be due to the experimental set-up
used in the various studies or species differences. Further-
more, of notice is also that both AMPK and p38 have
been reported to phosphorylate and thereby activate
PGC-1a (Puigserver et al. 2001; Jager et al. 2007), and it
is therefore possible that the observed changes in AMPK
and p38 phosphorylation elicited differences in PGC-1a
activity between the protocols in the present study. How-
ever, this speculation remains to be clarified.
The current observation that Cyt c mRNA levels did
not change significantly in any of the protocols is consis-
tent with previous studies (Pilegaard et al. 2005; Leick
et al. 2010), because mRNA content of various oxidative
proteins has been shown to remain unchanged within the
initial 6 h of recovery from exercise (Pilegaard et al.
2003), and Cyt c mRNA was first elevated 10 h after exer-
cise (Leick et al. 2010). Nevertheless, numerous studies
have reported that PGC-1a regulates the expression of
Cyt c in skeletal muscle (Puigserver et al. 2001; Lin et al.
2002; Leick et al. 2008, 2010), which may also have been
the case in the present study. The present finding that the
overall response of VEGF mRNA resembled the PGC-1a
mRNA pattern may suggest that the changes in VEGF
mRNA were not elicited by changes in PGC-1a expres-
sion. However, it cannot be ruled out that regulation of
PGC-1a activity through post translational modifications
mediated the observed increase in VEGF mRNA as previ-
ously suggested (Jensen et al. 2004).
In conclusion, the present data suggest that differences
in plasma adrenaline and muscle metabolic stress during
exercise do not reinforce exercise-induced PGC-1a mRNA
response in human skeletal muscle. In addition,
differences in exercise-induced AMPK and p38 signaling
were not associated with differences in the PGC-1a
mRNA responses, which do not support that AMPK and
p38 signaling determines the magnitude of the exercise-
induced PGC-1a mRNA responses in human muscle.
Study limitations
It is important to mention that the specific time points in
the current study may not have caught the actual peak
inductions of the different mRNAs due to the transient
nature of the responses, and that the timing of the peak
may have been different between protocols. For example,
the response may be delayed in CS, where sprinting was
clustered by the end of the protocol and thus it cannot
be ruled out that the enhanced intracellular signaling in
CS did affect the PGC-1a mRNA response, but at a time
point not investigated. Unfortunately, resolving this issue
would require continuous measurements, which clearly is
not possible in the current experimental setting. In addi-
tion, as described in the statistics section, the variations
in mRNA were larger than anticipated.
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